title: [Description of French general practitioners' practices regarding long term systemic corticosteroid therapy-associated measures].
abstract: BACKGROUND
  Except for the prevention of osteoporosis, no consensual recommendations are available regarding the therapeutic measures associated with the prescription of a long term corticosteroid therapy. We assessed the French general practitioners'practices regarding the prescription of these measures.
  
  
  METHODS
  In September 2007, we sent by e-mail a questionnaire to 860 general practitioners members of the reseau Sentinelles, a national survey system which collect data from volunteers French general practitioners. We assessed the frequency of prescription of measures associated with systemic corticosteroids and for whom no consensual recommendations were available (dietary advices, physical training, potassium supplementation, gastric protection, influenza vaccination, prescription of hydrocortisone).
  
  
  RESULTS
  293 out of 860 general practitioners completed the questionnaire (response rate: 34%). The practitioners were predominantly male (87%). Regarding the dietary measures, low sodium diet was recommended by most of the physicians, 68% of them prescribing such dietary regimen in more than 80% of their corticosteroid-treated patients. The concomitant prescription of caloric restriction, low carbohydrate diet or high protein diet was not consensual. Prescriptions of muscular physiotherapy and gastric protection were unusual (80% and 67% of physicians prescribing these measures in less than 20% of their patients, respectively). Recommendations for daily physical training, potassium supplementation, influenza vaccination or hydrocortisone prescription were not consensual.
  
  
  CONCLUSIONS
  There is no consensus in the French general practitioners community regarding most of the measures associated with a long term systemic corticosteroid therapy.
authors.affiliation: AP-HP, service de médecine interne, hôpital Saint-Antoine, 75012 Paris, France.
authors.forename: Aurélie
authors.initials: A
authors.lastname: Perdoncini-Roux
authors.forename: Thierry
authors.initials: T
authors.lastname: Blanchon
authors.forename: Thomas
authors.initials: T
authors.lastname: Hanslik
authors.forename: Andrea
authors.initials: A
authors.lastname: Lasserre
authors.forename: Clément
authors.initials: C
authors.lastname: Turbelin
authors.forename: Yves
authors.initials: Y
authors.lastname: Dorleans
authors.forename: Jean
authors.initials: J
authors.lastname: Cabane
authors.forename: Laurence
authors.initials: L
authors.lastname: Fardet
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D003430:Cross-Sectional Studies; D005194:Family Practice; D005260:Female; D005602:France; D006801:Humans; D008297:Male; D008875:Middle Aged; D010818:Practice Patterns, Physicians'; D011795:Surveys and Questionnaires; D013997:Time Factors
chemical_list: D000305:Adrenal Cortex Hormones